DemocratBill · H.R. 1620· House(119-HR-1620)

Finn Sawyer Access to Cancer Testing Act

Rep. Matsui
Age: 82 years
California
Introduced
2/26/2025
Last activity
2/26/2025 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sponsored by
Doris Matsui
Cosponsors
Democrat - 11Republican - 2
Health
  1. Introduced
  2. In Committee

What this bill would do

The Finn Sawyer Access to Cancer Testing Act aims to facilitate the development of cancer treatments. This bill expands coverage for cancer diagnostic and laboratory tests, including DNA and RNA sequencing, under Medicare, Medicaid, and CHIP. It establishes specific rules for how often these tests can be used for patients diagnosed with or experiencing a recurrence of cancer. Additionally, the bill mandates an education and awareness program regarding genomic testing. This program is intended to inform physicians and the general public about the use of such tests and the role of genetic counselors.

Yes· 3 of 9

  • Would people over 65 be better off under this?+7

    The bill expands Medicare coverage for cancer diagnostic tests and removes the deductible for these services.

  • Would households on low incomes be better off under this?+7

    The bill expands coverage for essential cancer diagnostic tests through Medicaid and CHIP.

  • Does this make health care easier to get in general?+7

    The bill increases access to advanced cancer diagnostics, including genomic sequencing, through Medicare, Medicaid, and CHIP.

The opposite

No question was scored the opposite.